Advertisement
Journal Home
Search for

Volume 90, Issue 2, Pages 145-151 (March 2010)


View previous. 9 of 10 View next.

Breath biomarkers of active pulmonary tuberculosis

Michael PhillipsabCorresponding Author Informationemail address, Victoria Basa-Dalaychemail address, Graham Bothamleydiemail address, Renee N. Cataneoajemail address, Phung Kim Lamekemail address, Maria Piedad R. Natividadflemail address, Peter Schmittgmemail address, James Waiajemail address

Received 27 October 2009; received in revised form 18 January 2010; accepted 26 January 2010. published online 02 March 2010.

Summary 

Background

Volatile organic compounds (VOCs) in breath may contain biomarkers of active pulmonary tuberculosis derived from the infectious organism (metabolites of Mycobacterium tuberculosis) and from the infected host (products of oxidative stress).

Methods

We analyzed breath VOCs in 226 symptomatic high-risk patients in USA, Philippines, and UK, using gas chromatography/mass spectroscopy. Diagnosis of disease was based on sputum culture, smear microscopy, chest radiography and clinical suspicion of tuberculosis (CSTB). Chromatograms were converted to a series of 8s overlapping time slices. Biomarkers of active pulmonary tuberculosis were identified with a Monte Carlo analysis of time-slice alveolar gradients (abundance in breath minus abundance in room air).

Results

Breath VOCs contained apparent biomarkers of active pulmonary tuberculosis comprising oxidative stress products (alkanes and alkane derivatives) and volatile metabolites of M. tuberculosis (cyclohexane and benzene derivatives). Breath biomarkers identified active pulmonary tuberculosis with C-statistic (area under curve of receiver operating characteristic)=0.85 (i.e. 85% overall accuracy, sensitivity=84.0%, specificity=64.7%) when sputum culture, microscopy, and chest radiography were either all positive or all negative. Employing a single criterion of disease, C-statistic=0.76 (smear microscopy), 0.68 (sputum culture), 0.66 (chest radiography) and 0.65 (CSTB).

Conclusion

A breath test identified apparent biomarkers of active pulmonary tuberculosis with 85% accuracy in symptomatic high-risk subjects.

a Menssana Research Inc., 1 Horizon Road, Suite 1415, Fort Lee, NJ 07024-6510, United States

b Department of Medicine, New York Medical College, Valhalla, NY, United States

c Tuberculosis Research Unit, Angelo King Medical Research Center, De La Salle Health Sciences Institute, Cavite, Philippines

d Department of Respiratory Medicine, Homerton University Hospital NHS Foundation Trust, London E9 6SR, England, UK

e Division of Pulmonary and Critical Care Medicine, University of California San Diego, 200 West Arbor Drive, San Diego, CA 92103-8374, USA

f Center for Respiratory Medicine, The University of Santo Tomas Hospital (USTH), España Boulevard, Manila 1008, Philippines

g Schmitt & Associates, 211 Warren St, Newark, NJ 07103, United States

Corresponding Author InformationCorresponding author. Menssana Research Inc., 1 Horizon Road, Suite 1415, Fort Lee, NJ 07024-6510, United States. Tel./fax: +1 201 886 7004.

h Tel.: +63 46 416 0226x238.

i Tel.: +44 (0) 20 8510 7814.

j Tel.: +1 973 643 5464.

k Tel.: +1 619 543 5550; fax: +1 619 543 3276.

l Tel.: +63 (02) 731 3001.

m Tel.: +1 973 733 2225.

PII: S1472-9792(10)00015-6

doi:10.1016/j.tube.2010.01.003


View previous. 9 of 10 View next.

Advertisement